Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Effects of sex hormones on Alzheimer's disease-associated β-amyloid oligomer formation in vitro.

Morinaga A, Ono K, Takasaki J, Ikeda T, Hirohata M, Yamada M.

Exp Neurol. 2011 Apr;228(2):298-302. doi: 10.1016/j.expneurol.2011.01.011. Epub 2011 Jan 31.

PMID:
21281631
2.

Estrogen has anti-amyloidogenic effects on Alzheimer's beta-amyloid fibrils in vitro.

Morinaga A, Hirohata M, Ono K, Yamada M.

Biochem Biophys Res Commun. 2007 Aug 3;359(3):697-702. Epub 2007 Jun 4.

PMID:
17559807
3.

Effects of antiparkinsonian agents on β-amyloid and α-synuclein oligomer formation in vitro.

Ono K, Takasaki J, Takahashi R, Ikeda T, Yamada M.

J Neurosci Res. 2013 Oct;91(10):1371-81. doi: 10.1002/jnr.23256. Epub 2013 Aug 1.

PMID:
23913715
4.

Silibinin: a novel inhibitor of Aβ aggregation.

Yin F, Liu J, Ji X, Wang Y, Zidichouski J, Zhang J.

Neurochem Int. 2011 Feb;58(3):399-403. doi: 10.1016/j.neuint.2010.12.017. Epub 2010 Dec 24.

PMID:
21185897
5.

Preparation of stable amyloid β-protein oligomers of defined assembly order.

Rosensweig C, Ono K, Murakami K, Lowenstein DK, Bitan G, Teplow DB.

Methods Mol Biol. 2012;849:23-31. doi: 10.1007/978-1-61779-551-0_3.

PMID:
22528081
6.

Tetracycline and its analogues protect Caenorhabditis elegans from β amyloid-induced toxicity by targeting oligomers.

Diomede L, Cassata G, Fiordaliso F, Salio M, Ami D, Natalello A, Doglia SM, De Luigi A, Salmona M.

Neurobiol Dis. 2010 Nov;40(2):424-31. doi: 10.1016/j.nbd.2010.07.002. Epub 2010 Jul 14.

PMID:
20637283
7.

The potential use of hormone-based therapeutics for the treatment of Alzheimer's disease.

Carroll JC, Rosario ER.

Curr Alzheimer Res. 2012 Jan;9(1):18-34. Review.

PMID:
22329650
8.

Protective actions of sex steroid hormones in Alzheimer's disease.

Pike CJ, Carroll JC, Rosario ER, Barron AM.

Front Neuroendocrinol. 2009 Jul;30(2):239-58. doi: 10.1016/j.yfrne.2009.04.015. Epub 2009 May 7. Review.

9.

Functional interactions of fibrillar and oligomeric amyloid-β with alpha7 nicotinic receptors in Alzheimer's disease.

Lilja AM, Porras O, Storelli E, Nordberg A, Marutle A.

J Alzheimers Dis. 2011;23(2):335-47. doi: 10.3233/JAD-2010-101242.

PMID:
21116052
10.

Stabilization of native amyloid β-protein oligomers by Copper and Hydrogen peroxide Induced Cross-linking of Unmodified Proteins (CHICUP).

Williams TL, Serpell LC, Urbanc B.

Biochim Biophys Acta. 2016 Mar;1864(3):249-59. doi: 10.1016/j.bbapap.2015.12.001. Epub 2015 Dec 15.

PMID:
26699836
11.

[Involvement of beta-amyloid in the etiology of Alzheimer's disease].

Tomiyama T.

Brain Nerve. 2010 Jul;62(7):691-9. Review. Japanese.

PMID:
20675873
12.

Lipid oxidation and modification of amyloid-β (Aβ) in vitro and in vivo.

Ellis G, Fang E, Maheshwari M, Roltsch E, Holcomb L, Zimmer D, Martinez D, Murray IV.

J Alzheimers Dis. 2010;22(2):593-607. doi: 10.3233/JAD-2010-100960.

PMID:
20847409
13.

Crystal structure of the amyloid-β p3 fragment provides a model for oligomer formation in Alzheimer's disease.

Streltsov VA, Varghese JN, Masters CL, Nuttall SD.

J Neurosci. 2011 Jan 26;31(4):1419-26. doi: 10.1523/JNEUROSCI.4259-10.2011.

15.

Diverse ecdysterones show different effects on amyloid-β42 aggregation but all uniformly inhibit amyloid-β42-induced cytotoxicity.

Yang SG, Zhang X, Sun XS, Ling TJ, Feng Y, Du XY, Zhao M, Yang Y, Xue D, Wang L, Liu RT.

J Alzheimers Dis. 2010;22(1):107-17. doi: 10.3233/JAD-2010-100621.

PMID:
20847437
16.
17.

Reproductive hormones modulate oxidative stress in Alzheimer's disease.

Barron AM, Fuller SJ, Verdile G, Martins RN.

Antioxid Redox Signal. 2006 Nov-Dec;8(11-12):2047-59. Review.

PMID:
17034349
18.

Enoxaparin treatment administered at both early and late stages of amyloid β deposition improves cognition of APPswe/PS1dE9 mice with differential effects on brain Aβ levels.

Timmer NM, van Dijk L, van der Zee CE, Kiliaan A, de Waal RM, Verbeek MM.

Neurobiol Dis. 2010 Oct;40(1):340-7. doi: 10.1016/j.nbd.2010.06.008. Epub 2010 Jun 22.

PMID:
20600909
19.

[Pathological changes induced by amyloid-β in Alzheimer's disease].

Takata K, Kitamura Y, Taniguchi T.

Yakugaku Zasshi. 2011 Jan;131(1):3-11. Review. Japanese.

20.

Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β.

Tayler H, Fraser T, Miners JS, Kehoe PG, Love S.

J Alzheimers Dis. 2010;22(4):1363-73. doi: 10.3233/JAD-2010-101368.

PMID:
20930272

Supplemental Content

Support Center